Floatz logo

1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1)

Extensive Stage Lung Small Cell Carcinoma

SWOG Cancer Research NetworkSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

12 Active assets in the Extensive Stage Lung Small Cell Carcinoma cohort.

Asset / SponsorPhaseRating
Iadademstat
Yale University
Phase 2BB
Niraparib
ETOP IBCSG Partners Foundation
Phase 3BB
Tas-102
Taiho Oncology, Inc.
Phase 2B
azd5305
SWOG Cancer Research Network
Phase 2B
Talzenna
University Health Network, Toronto
Phase 2B

View all 15 →

Same molecule, other indications

1H-BENZIMIDAZOLE, 2-(((4-(3-METHOXYPROPOXY)-3-METHYL-2-PYRIDINYL)METHYL)SULFINYL)-, SODIUM SALT, HYDRATE (1:1:1) is also rated in:

Metastatic Castration-Sensitive Prostate CancerDormant
B
Indicative ·
60 / 100
View asset →
Endoscopic Variceal Band LigationDormant
B
Indicative ·
60 / 100
View asset →
gastroesophageal reflux diseaseDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →